Document:

EX-10.1

 Exhibit 10.1 

Nabriva Therapeutics AG 

Stock Option Plan 2007 
  

							
	 I.
		 Introduction
		 	2	  
			
	 II.
		 Structure of the Stock Option Plan
		 	2	  
			
	 A.
		 Options
		 	2	  
			
	 1.
		 Vesting
		 	3	  
			
	 2.
		 Exercise Price
		 	4	  
			
	 3.
		 Exercising vested options
		 	5	  
			
	 4.
		 Rights and restrictions attached to vested options
		 	6	  
			
	 B.
		 Termination of Employment or Board Position
		 	6	  
			
	 1.
		 Good Leaver Events
		 	6	  
			
	 2.
		 Bad Leaver Events
		 	7	  
			
	 3.
		 Exercised options
		 	8	  
			
	 4.
		 Accelerated Vesting
		 	8	  
			
	 C.
		 Duration, Expiry, Amendments to and Termination of the Stock Option Plan
		 	8	  
			
	 1.
		 Duration and Expiry
		 	8	  
			
	 2.
		 Termination
		 	9	  
			
	 D.
		 Future participants
		 	9	  
			
	 E.
		 Risks
		 	9	  
			
	 F.
		 Miscellaneous
		 	10	  
			
	 1.
		 Stock Adjustments
		 	10	  
			
	 2.
		 No business practice (“Betriebliche Übung”)
		 	11	  
			
	 3.
		 Taxes, duties and social contributions
		 	11	  
			
	 4.
		 Notices
		 	12	  
			
	 5.
		 Saving provisions
		 	12	  
			
	 6.
		 English Version
		 	12	  
			
	 7.
		 Governing law and jurisdiction
		 	12	  

 I. INTRODUCTION 

On 12 September 2007 the Managing Board and the Supervisory Board of Nabriva Therapeutics Forschungs AG (“Nabriva” or the
“Company”) resolved to implement a stock option plan for all employees ( for the avoidance of doubt including members of the Managing Board) being employed with the Company for an indefinite period of time at 28 September 2007
and selected members of the Supervisory Board of the Company and further participants (the “Beneficiaries”, see below Annex ./2) subject to the provisions as set forth herein (the “Stock Option Plan” or
“SOP”). 
 When the conditions of the Stock Option Plan are met, options will be granted to the Beneficiaries. These options will grant the
Beneficiaries the right to acquire Shares in Nabriva or otherwise settle the options under the conditions set forth herein. Nabriva believes that this Stock Option Plan enhances the commitment of the Beneficiaries to contribute to Nabriva’s
success by allowing them to participate in the increase in the value of the Company. 
 The potential Beneficiaries have been personally informed about the
Stock Option Plan. The provisions set forth herein regulate the Stock Option Plan in its entirety. If any of the information communicated to the potential participants of the SOP diverges from this SOP, the provisions of this SOP shall prevail. 

Options pursuant to this SOP are neither granted as remuneration nor as bonus in exchange for the performance of Beneficiaries during a specific period.
Rather, the participation in this SOP and the vesting of options pursuant to this SOP constitute a voluntary benefit of the Company. Following the nature of voluntary benefits these are solely granted to foster the motivation and solidarity of all
Beneficiaries. 
 II. STRUCTURE OF THE STOCK OPTION PLAN 
  

	A.	Options 

 The aggregate and overall number of options eligible to be granted and vested to all
Beneficiaries under the Stock Option Plan shall not exceed 29,889 (the “Overall Number of Options”). The number of options eligible to be granted per Beneficiary is set out in Annex ./2 hereto. Notwithstanding the date and duration
of their participation herein and without prejudice to the provisions of this Stock Option Plan, Beneficiaries shall not be entitled to (further) options under this Stock Option Plan once the Overall Number of Options are granted. 

  
 - 2 - 

	1.	Vesting 

 The period in which granted options are vested in accordance with the SOP (“Vesting
Period”) shall be four years. The Vesting Period shall commence on the date of participation of the Beneficiaries in this SOP (“Date of Participation”) as set out in Annex ./3 hereto, but in any event not before
28 September 2007. The total number of granted options eligible to be vested per Beneficiary is set out in Annex ./2 hereto. 
  

	 	(i)	Year 1 

 On the last day of the last calendar month of the first year of the Vesting Period following the Date
of Participation, 25 % of the options eligible to be vested per Beneficiary shall be vested automatically with that Beneficiary. 
  

	 	(ii)	Year 2 

 On the last day of the last calendar month of the second year of the Vesting Period following the Date
of Participation, 25 % of the options eligible to be vested per Beneficiary shall be vested automatically with that Beneficiary. 
  

	 	(iii)	Year 3 and Year 4 

 During the third and fourth year of the Vesting Period following the Date of Participation,
the remaining 50 % of the options eligible to be vested per Beneficiary shall be vested with that Beneficiary on a monthly pro rata basis (i.e. 2.083 % per month). Options eligible to be vested for any given month in years three and
four of the Vesting Period will be vested automatically on the last day of each calendar month. 
 Notwithstanding the above, regarding all Beneficiaries
that have worked for the Company prior to their Date of Participation in the SOP, (i) 25 % of the options eligible to be vested per Beneficiary shall be vested automatically on the last day of the month marking the (first) anniversary of
their employment with the Company following their Date of Participation and (ii) 25 % of the options eligible to be vested per Beneficiary shall be vested automatically on the last day of the month marking the following next anniversary of
their employment with the Company. The remaining 50 % of the options shall be vested with that Beneficiary on a monthly pro rata basis (i.e. 2.083 % per month) as set forth in (iii) above. 

  
 - 3 - 

 Certain Beneficiaries that have worked for the Company for a minimum period of at least one year prior to their
Date of Participation in the SOP (the “Qualified Beneficiaries”) shall be vested 25 % of the options eligible to be vested per Beneficiary under the SOP as set forth in Annex ./2 and ./3 immediately on the Date of
Participation of the Qualified Beneficiaries. 25 % of the options eligible to be vested shall be vested on the last day of the month marking the anniversary of their employment with the Company following their Date of Participation, whereas
anniversary of their employment with the Company always means February 1 if the Qualified Beneficiary started working for the Company before 1 February 2006. The remaining 50 % of the options shall be vested with that Beneficiary on a
monthly pro rata basis (i.e. 2.083 % per month) as set forth in (iii) above. 
 The Company believes this will further enhance the Qualified
Beneficiaries’ motivation and solidarity with Nabriva. 
 Options shall be vested to Beneficiaries taking maternity leave (“Maternity Leave
Employees”) in accordance with this Clause II.A.1, provided that (i) options shall not be vested during the time the Maternity Leave Employee is on maternity leave and (ii) options shall only be vested when the
Maternity Leave Employee has worked for Nabriva for a continuous period (such period calculated from the first day the Maternity Leave Employee resumes work after maternity leave) of at least (x) 12 months or (y) 1 month if the Maternity
Leave Employee is participating in the third or fourth year of the Vesting Period pursuant to item (iii) in this Clause. 
 For the avoidance of doubt,
options vested prior to the Maternity Leave Employee having taken maternity leave shall not be forfeited. 
  

	2.	Exercise Price 

 The exercise price shall be determined by an Austrian Independent Certified Public
Accountant (Wirtschaftsprüfer) appointed by the Company (“Expert Evaluator”) based on the fair market value of the Shares initially as of 31 July 2007, and thereafter as of 31 December of each financial year of
the Company (“Exercise Price Date”) pursuant to the Gross Procedure of the Discounted Cash Flow Method based on the rules and guidelines of the Chamber of Public Accountants on the Company value (KFS BW1 -
Fachgutachten des Fachsenats für Betriebswirtschaft und Organisation des Instituts für Betriebswirtschaft, Steuerrecht und Organisation der Kammer der Wirtschaftstreuhänder über die Unternehmensbewertung) (“Exercise
Price”). 

  
 - 4 - 

 Subject to the provisions set forth herein, each vested option entitles a Beneficiary to acquire one Share at the
Exercise Price. The Exercise Price so determined for the most recent Exercise Price Date prior to the participation of the employee shall apply to all vested options exercised by a Beneficiary under this SOP. 

The Company shall pay for any costs arising in connection with the determination of the Exercise Price. 

 

	3.	Exercising vested options 

 The exercise of a vested option is only permissible in case of a Liquidation
Event or a Qualified Public Offering. The Beneficiaries are entitled to exercise the vested options from 28 September 2007 until 27 September 2017 (“Exercise Period”). Save for the case of a Liquidation Event the
Beneficiaries are entitled to exercise vested options exclusively within a period commencing the day after the Company’s annual general meeting and ending six weeks after that day. 

In order to exercise a vested option, the Beneficiary must notify the Company by submitting an exercise notice to the Company in the form of Annex ./4
(“Exercise Notice”) one week prior to the date he wishes to exercise the option as specified in the Exercise Notice. 
 In case of a
Qualified Public Offering, the transfer of the shares to the Beneficiaries due to the exercise of options under this SOP is effected only upon completion of the Qualified Public Offering. 

In case of a Liquidation Event, the Beneficiaries will – following their exercise of options – only receive a portion of the remainder, if any, of
the proceeds from such Liquidation Event after satisfaction of the holders of certain preferred shares pursuant to liquidation preference agreements as in force at the date of exercise of options, whereas the Beneficiaries will participate in such
remainder, if any, pro rata corresponding to their shareholding in the Company (in case Shares would have been transferred to the Beneficiaries); whereas the Company in case of a distributable remainder in its sole discretion may opt to
provide the Beneficiaries with Shares in the Company rather than with cash amounts. A Beneficiary’s obligation to deposit the Exercise Price shall be subject to notification by the Company that a distributable remainder exists. 

  
 - 5 - 

	4.	Rights and restrictions attached to vested options 

 The Beneficiaries shall not be entitled to transfer
vested options, except to individuals by way of inheritance or bequest. For the avoidance of doubt, Beneficiaries shall also not be entitled to transfer vested options by virtue of bilateral legal transactions causa mortis with or without
consideration. 
 The Beneficiaries shall not be entitled to grant rights to, encumber or dispose of vested options in any other manner (in particular
pledge, transfer by way of security or derivative transactions having the same commercial effect). 
 Options do not entitle the Beneficiary to exercise any
shareholder rights. The Beneficiary may only exercise shareholder rights if and to the extent it holds Shares. 
 In the event of a Bankruptcy of a
Beneficiary, the options not yet exercised by such Beneficiary shall automatically be forfeited. 
 Any options not exercised by the end of the Exercise
Period shall automatically and finally lapse and be forfeited. 
  

	B.	Termination of Employment or Board Position 

 In case employment or board position of a Beneficiary is
terminated, the following shall apply: 
  

	1.	Good Leaver Events 

 If a Beneficiary’s service or employment relationship ends during the term of
the SOP due to (and each of the following a “Good Leaver Event”) 
  

	 	(i)	retirement due to age or permanent disability (Ausscheiden aufgrund Alters oder dauernder Arbeitsunfähigkeit); 

  

	 	(ii)	death; 

  

	 	(iii)	ordinary termination by maintaining the contractual or statutory periods and deadlines (ordentliche Kündigung) by the Company or the Beneficiary; 

  
 - 6 - 

	 	(iv)	justified premature resignation with immediate effect (berechtigter vorzeitiger Austritt); 

  

	 	(v)	unjustified discharge with immediate effect (ungerechtfertigte Entlassung); 

  

	 	(vi)	mutual termination (einvernehmliche Auflösung); 

  

	 	(vii)	expiry of a Managing Board or Supervisory Board mandate (Nichtverlängerung eines Mandats); 

  

	 	(viii)	premature revocation of a Managing Board or Supervisory Board mandate without good cause (Abberufung ohne wichtigen Grund); or 

 

	 	(ix)	resignation of a member of the Managing Board or Supervisor Board with good cause (Rücktritt aus wichtigem Grund); 

all rights and entitlements under the SOP to the options which have not been vested upon the occurrence of a Good Leaver Event shall be automatically
forfeited. Options eligible to be vested to a Beneficiary in a fiscal year which are not actually vested in respect of such Beneficiary in that fiscal year shall not be available to that Beneficiary at any other time. 

Beneficiaries with options vested but not exercised at the time of a Good Leaver Event shall retain such options and be entitled to exercise such options
according to the provisions set forth herein. 
  

	2.	Bad Leaver Events 

 If a Beneficiary’s service or employment relationship with the Company ends
during the term of the SOP due to an event other than a Good Leaver Event (a “Bad Leaver Event”), all options of the Beneficiary vested but not exercised at the time a Bad Leaver Event occurs shall forfeit. The revocation of a
member of the Managing Board pursuant to a vote of non confidence by the General Assembly shall not constitute a Bad Leaver Event as long as no reason for justified dismissal is set by the Beneficiary. 

The Supervisory Board may within its discretion decide whether to grant to a Beneficiary advantages as from a Good Leaver event even though the end of a
Beneficiary’s service or employment relationship constitutes a Bad Leaver Event as described in B.2. In case the Beneficiary concerned functions as a member of the Supervisory Board, the shareholders shall decide on the advantages granted to
the Beneficiary as set forth above. 

  
 - 7 - 

	3.	Exercised options 

 The termination of a service or an employment relationship with the Company shall
have no effect on options that were exercised prior to the date of a declaration of termination of employment or board position. 
  

	4.	Accelerated Vesting 

 In case a Liquidation Event occurs, 50% of the remaining options not yet vested
with a Beneficiary at this point in time, shall vest with the Beneficiaries with immediate effect. 
 In case of unjustified termination of the Beneficiary
by the Company or justified premature termination of employment by the Beneficiary (e.g. due to reduction in compensation, diminution of job responsibilities, permanent relocation of more than 50 kilometers) within one year after such Liquidation
Event occurred, all remaining options of a Beneficiary not yet vested at this point in time shall vest with the Beneficiary with immediate effect. 
 The
exercise of options vested pursuant to II.B.4 shall be subject to the provisions herein and in particular in II.A.3 except that the exercise period as defined under II.A.3. shall not apply. 

 

	C.	Duration, Expiry, Amendments to and Termination of the Stock Option Plan 

  

	1.	Duration and Expiry 

 The Stock Option Plan shall become effective on 28 September 2007. 

Beneficiaries shall have the right to exercise vested (but non-exercised) options until 27 September 2017. Thereupon, the Stock Option Plan shall
expire and all rights of the Beneficiaries under the Stock Option Plan shall terminate, in particular the right to exercise vested but non-exercised options. 

  
 - 8 - 

	2.	Termination 

 The Company may terminate the SOP in relation to a Beneficiary for good cause if that
Beneficiary breaches significant statutory or contractual obligations in connection with its service or employment relationship with the Company. Such good cause shall be a reason pursuant to sec 75 Austrian Stock Company Act (Aktiengesetz)
for members of the Managing Board and the Supervisory Board of the Company and pursuant to sec 27 Austrian Employees Act (Angestelltengesetz) for employees of the Company whereby the revocation of a member of the Managing Board pursuant to a
vote of non confidence by the General Assembly shall not constitute such good cause in the meaning of this paragraph as long as no reason for justified dismissal is set by the Beneficiary. To the extent the members of the Managing Board are
affected, the Supervisory Board shall exercise such termination right. To the extent members of the Supervisory Board are affected, the Company’s shareholders shall be competent to resolve upon such termination by simple majority. 

 

	D.	Future participants 

 The Managing Board may at its sole discretion decide on the conditions for the
inclusion of future participants other than those listed in Annex ./2 including but not limited to employees of the Company in accordance with the terms of this Stock Option Plan (“Future Participants”). The Supervisory Board
shall have such right of decision in relation to Future Participants which are members of the Managing Board. The shareholders shall have such right of decision in relation to Future Participants which are members of the Supervisory Board. 

 

	E.	Risks 

 Neither the Company nor any shareholder of the Company (or any of their officers, employees or
consultants) 
  

	 	(i)	assumes any responsibility or liability for the development of the value of the market price of the Shares; 

  

	 	(ii)	warrant, assure or guarantee any increase in value of the Shares, in particular it is neither warranted, assured or guaranteed that a Beneficiary will be able to sell his participation in the Company with a profit in
the future nor that no loss will be incurred; 

  

	 	(iii)	warrant, assure or guarantee a profit of a Beneficiary from this Stock Option Plan. 

  
 - 9 - 

 Each Beneficiary declares with his participation in the SOP that the participation is voluntary. Each Beneficiary
is aware of the fact that he alone bears the risk of a decrease in or total loss of value of his investments. Each Beneficiary accepts the offer to participate in the Stock Option Plan at his own risk and assumes any liability relating thereto. 

Each Beneficiary is responsible for obtaining legal and tax advice before participating in the SOP and for evaluating the tax effects connected with the Stock
Option Plan. Each Beneficiary accepts and declares that he has not been advised by or on behalf of the Company with respect to his participation in the Stock Option Plan (in particular regarding legal and tax issues of the participation). 

The Company declares to undertake the best efforts for a risk minimal and tax efficient settlement of this SOP. 

 

	F.	Miscellaneous 

  

	1.	Stock Adjustments 

 If, during the term of the SOP, changes to the capital of the Company or
restructuring measures have an effect on the capital of the Company, such as a stock split or reverse split of stocks, (together “Stock Adjustments”) which result in a change in the value of the options, the Company is entitled to
adjust the price or the amount of the options respectively, to the extent necessary to compensate changes in value (but not a dilution of shareholding) resulting from any Stock Adjustments. For the avoidance of doubt, this Clause shall not apply to
measures, such as future financing rounds, in which new shareholders of the Company are introduced. 
 The Supervisory Board decides on an adjustment based
on a proposal by the Managing Board. After execution of the Stock Adjustments the total value of the granted options shall equal the total value of the options before execution of such Stock Adjustments. The Company will inform the Beneficiaries
about the Stock Adjustment and the effective date of the Stock Adjustment. 

  
 - 10 - 

	2.	No business practice (“Betriebliche Übung”) 

 The granting of
options and the implementation of the SOP is the free and discretionary choice of the Company, constitutes a voluntary benefit and shall not give rise to any legal claim by a Beneficiary for the future, not even in the case of repeated granting.

 Beneficiaries of the SOP do not have a right for the introduction of another option plan or any vesting of options in addition to those under the Stock
Option Plan, even if the Company implements any other option plan or vests further options under any other option plan. 
 Vested options under this Stock
Option Plan do not affect the calculation of severance, premiums, royalties, pension plans or any other remuneration of the Beneficiary. 
  

	3.	Taxes, duties and social contributions 

 All taxes, social contributions, further duties and costs
accrued by the Beneficiary in connection with its participation in the SOP or due to the distribution of profits shall be borne by each Beneficiary. Each Beneficiary is obliged to pay taxes relating to the respective options granted/exercised under
the SOP to the competent tax authorities, also in the course of tax audits or any other procedures. Each Beneficiary shall fully indemnify the Company in respect of all such liabilities and obligations against tax authorities. 

The employer of the Beneficiary is entitled, if required by statutory law, to withhold wage tax or any other taxes or duties or social contributions to be
paid by the Beneficiary. This applies even after termination of the employment of a Beneficiary with the Company, if the vested options granted are non-lapsable but not yet exercisable. The Company is entitled to demand the full cooperation of the
Beneficiary even after his leave with respect to the withholding of taxes, social contributions, other duties and costs in connection with this Stock Option Plan. The Beneficiary undertakes to co-operate. 

Withholdings mentioned above do not release the Beneficiary from his responsibility and obligation to pay all taxes, social contributions, further duties and
costs being due and accruing in connection with his participation in the SOP or in connection with the distribution of profits. 

  
 - 11 - 

	4.	Notices 

 Notifications to the Company with respect to the terms of the Stock Option Plan shall only be
made to: 
 Nabriva Therapeutics AG 
 Corporate Human Resources

			
	fax:		+43 1 866 59 785
	email:		ralf.schmid@nabriva.com

 Notifications by the Company of the Beneficiary relating to the SOP shall be made in writing (including email or fax) to each
Beneficiary to the respective Beneficiary’s address last disclosed to the Company. 
  

	5.	Saving provisions 

 If any provision of this SOP in full or in part is or becomes invalid, this shall not
affect the validity of all other provisions or the valid part of an invalid provision. To the extent legally possible, an agreement shall be made replacing the invalid provision by a provision which best meets the intent of the terms of the SOP. The
same applies to loopholes of the terms of the SOP, which may arise in the course of implementation of the terms of the SOP. 
  

	6.	English Version 

 This SOP is concluded in a German and English version. For disputes pursuant to this
SOP, the English version shall prevail. 
  

	7.	Governing law and jurisdiction 

 The terms of the SOP, its interpretation and all rights and obligations
arising there from shall be governed by Austrian law, except for international private law and the UN Convention on Contracts for the International Sales of Goods. The courts of Vienna, Austria, shall, to the extent legally possible, have exclusive
jurisdiction regarding all claims in connection with the SOP and the terms of the SOP. 
 Annex: 

 

	./1	Definitions 

  

	./2	List of eligible options per Beneficiary 

  

	./3	Accession Statement 

  

	./4	Exercise Notice 

  
 - 12 - 

 Annex ./1 

I. Definitions 
  

			
	Bad Leaver Event		has the meaning ascribed thereto in Clause II.C.2 (“Bad Leaver Events”).
		
	Bankruptcy		means the initiation of bankruptcy proceedings in regard to the assets of a Beneficiary, the dismissal of an application for bankruptcy due to a lack of assets or the initiation of private bankruptcy proceedings pursuant to
secs. 181 et seq. of the Austrian Bankruptcy Code (“KO”) or any equivalent rule in any other relevant jurisdiction.
		
	Beneficiaries		are all employees ( for the avoidance of doubt including members of the Managing Board) being employed with the Company for an indefinite period of time at 28 September 2007 and selected members of the Supervisory Board of the
Company and further participants (see below Annex ./2) subject to the provisions as set forth herein under this SOP.
		
	Company		Nabriva Therapeutics AG and its legal successors.
		
	Date of Participation		means the date of entry of Beneficiaries in this SOP.
		
	Exercise Notice		has the meaning ascribed thereto in Clause II.A.3 (“Exercising vested options”).
		
	Exercise Period		has the meaning ascribed thereto in Clause II.A.3 (“Exercising vested options”).
		
	Exercise Price		has the meaning ascribed thereto in Clause II.A.2 (“Exercise Price”).
		
	Exercise Price Date		has the meaning ascribed thereto in Clause II.A.2 (“Exercise Price”).
		
	Expert Evaluator		has the meaning ascribed thereto in Clause II.A.2 (“Exercise Price”).

  
 - 13 - 

			
		
	Future Participants:		has the meaning ascribed thereto in Clause II.D. (“Future Participants”).
		
	Good Leaver Event		has the meaning ascribed thereto in Clause II.C.1 (“Good Leaver Events”).
		
	Liquidation Event		means (i) an exclusive license of or the sale or other disposal of 50 % or more of the assets of the Company, (ii) a sale or other disposal (for the avoidance of doubt, the term disposal shall not include a pledge) of 50 %
or more of the shares of the Company, (iii) a merger of the Company with any third party, or (iv) a consolidation, liquidation, winding up or any other form of a dissolution of the Company.
		
	Managing Board		means the managing board (Vorstand) of the Company.
		
	Maternity Leave Employees		has the meaning ascribed thereto in Clause II.A (“Options”).
		
	Overall Number of Options		has the meaning ascribed thereto in Clause II.A (“Options”).
		
	Qualified Beneficiary		has the meaning ascribed thereto in Clause II.A (“Options”).
		
	Qualified Public Offering		means a qualified public offering of the shares of the Company at a fully diluted pre-money valuation of at least EUR 120 million with gross proceeds to the Company of not less than EUR 40 million.
		
	Shares		means the common shares of the Company issued from time to time and each a “Share”.
		
	SOP		has the meaning ascribed thereto in Clause I (“Introduction”).
		
	Stock Option Plan		has the meaning ascribed thereto in Clause I (“Introduction”).

  
 - 14 - 

			
		
	Supervisory Board		means the supervisory board (Aufsichtsrat) of the Company.
		
	Vesting Period		has the meaning ascribed thereto in Clause II.A.1 (“Vesting”).

  
 - 15 - 

 Annex ./2 

Eligible Options per Beneficiary 

Annex: 
  

	./	Option Distribution Table 

  
 - 16 - 

 Annex ./3 

Form of Accession Statement 
 To: 

Ms / Mr [●], 
 [address] 

REF: SOP / Accession Statement 
 Dear Ms / Mr [●], 

You will participate in this SOP with effect as of [●] (Participation Date). 

As Participant in the SOP you will be vested options to acquire shares in the Company pursuant to this SOP in the amounts as set forth in the Vesting Table
attached. 
  
  

Nabriva Therapeutics Forschungs AG: 
 DATE: 

PARTICIPANT: 
 DATE: 

Annex: 
  

	./	Vesting Table 

  
 - 17 - 

 Annex ./4 

Form of Exercise Notice 
 To: Nabriva
Therapeutics Forschungs AG 
 Corporate Human Resources 
 REF:
SOP / Exercise Notice 
 Dear Sirs, 
 I am a participant in
the SOP. Capitalized terms not otherwise defined herein shall have the meaning assigned to such term in the SOP. This is an Exercise Notice. 
 I hereby
irrevocably declare to exercise [●] vested options granted to me [on ●] 
  

	 	 ̈	When exercising above number of options, I wish to acquire [●] Shares as determined in the vesting table attached to my Accession Statement at the Exercise Price per Share. Such Shares shall be delivered to my
securities account no. [●] with [●] against (i) signing by me of the subscription declaration required pursuant to § 165 Austrian Stock Corporation Act and (ii) payment in cash by me of the Exercise Price for each
Share. I acknowledge that my employer will withhold taxes, duties or social contributions, if any, as applicable before determining the number of Shares to be delivered. 

 

	 	 ̈	Whereas in the case of a Liquidation Event, (i) I acknowledge that in case of a distributable remainder the Company – in consideration of the Exercise Price – in its sole discretion may opt to provide me
with Shares in the Company rather than with the cash amounts attributable to me according to the SOP, (ii) I shall deposit the Exercise Price only upon notification by the Company that a distributable remainder exists, (iii) upon such
notification, I shall deposit the Exercise Price within seven (7) business days. 

 I acknowledge that options have not been granted as
remuneration or as a bonus for job performance but rather as a voluntary benefit to encourage motivation and solidarity with the Company and that I have no entitlement to any future comparable benefits. 

 
  

 

	
	NAME:
	DATE:

  
 - 18 - 

 ADDENDUM 

with regard to the 
 Nabriva
Therapeutics AG’s 
 Stock Option Plan 

dated 12 September 2007 

 PREAMBLE 

WHEREAS, on 12 September 2007 the Managing Board and the Supervisory Board of Nabriva Therapeutics AG (Nabriva or the
Company) resolved to implement a stock option plan for all employees being employed by the Company for an indefinite period of time at 28 September 2007 and selected members of the Supervisory Board of the Company
and further participants (the Beneficiaries), a copy of which is attached hereto as Schedule 1 (the Stock Option Plan or SOP); 

WHEREAS, on 17 September 2009 the shareholders of the Company resolved to amend the SOP and thus, the Company is interested in amending the Stock Option
Plan according to such shareholders’ resolution through this addendum to the SOP (the Addendum). 
  

	1.	INTERPRETATION 

  

	1.1	Definitions 

 Unless explicitly stated otherwise herein, all capitalized terms used in this Addendum
shall have the meaning assigned to them in the SOP. 
  

	1.2	Supplemental 

 Except as explicitly provided herein, the SOP shall remain in full force and effect, and
this Addendum and the SOP shall be read and construed as one document. 
  

	2.	AMENDMENTS TO THE SOP 

 Section II. A. 3. of the SOP is
replaced so that it reads as follows: 
 “Exercising vested options 

The exercise of a vested option is only permissible in case of a Liquidation Event or a Qualified Public Offering. The Beneficiaries are entitled to
exercise the vested options from 28 September 2007 until 27 September 2017 (the Exercise Period). Save for the case of a Liquidation Event the Beneficiaries are entitled to exercise vested options exclusively within a
period commencing the day after the Company’s annual general meeting and ending six weeks after that day. 
 In order to exercise a vested
option, the Beneficiary must notify the Company by submitting an exercise notice to the Company in the form of Annex ./4 (Exercise Notice) one week prior to the date he wishes to exercise the option as specified in the Exercise
Notice. 
 In case of a Qualified Public Offering, the transfer of the shares to the Beneficiaries due to the exercise of options under this SOP is
effected only upon completion of the Qualified Public Offering. 
 In case of a Liquidation Event, the Beneficiaries will – following their
exercise of options – only receive a portion of the remainder, if any, of the proceeds from such 

  
 Page 2 

 Liquidation Event after satisfaction of the holders of certain preferred shares pursuant to liquidation
preference agreements as in force at the date of exercise of options, whereas the Beneficiaries will participate in such remainder, if any, pro rata corresponding to their shareholding in the Company (in case Shares would have been transferred to
the Beneficiaries); whereas the Company in case of a distributable remainder in its sole discretion may opt to provide the Beneficiaries with Shares in the Company rather than with cash amounts. A Beneficiary’s obligation to deposit the
Exercise Price shall be subject to notification by the Company that a distributable remainder exists. 
 Notwithstanding the foregoing, the
executives listed in Schedule ./2 hereto of the Company shall be entitled to exercise their respective vested option at any time prior to 31 December 2009 by giving an Exercise Notice regardless of whether a Liquidation Event or a
Qualified Public Offering has occurred (the Preferred Vested Option Right). In case such Preferred Vested Option Right is exercised, such executive’s receipt of the Shares shall be subject to the executive’s
accession to the Shareholders Agreement, then in force, entered into between the shareholders of the Company, and thus, the executive shall become a Party thereto with all rights and obligations entailed therein. Such Preferred Vested Option Right
is granted to the above-mentioned executives only because of their valuable contribution and commitment to the Company and as an additional incentive to further enhance the forthcoming the business thereof.” 

  
 Page 3 

 Schedule ./2 
  

	
	 Beneficiaries - Preferred Vested Option Right

 

	Dr. Rodger Novak - Leberstrasse 20, A-1110 Wien - geb. 22.06.1967 - Mitglied des Vorstandes
	Ralf Schmid - Leberstrasse 20, A-1110 Wien - geb. 12.04.1967 - Mitglied des Vorstandes
	Dr. William Prince - Leberstrasse 20, A-1110 Wien - geb. 06.01.1946 - Mitglied des Vorstandes

 SECOND ADDENDUM 

with regard to the 
 Nabriva
Therapeutics AG’s 
 Stock Option Plan 

dated 12 September 2007 

 PREAMBLE 

WHEREAS, on 12 September 2007 the Managing Board and the Supervisory Board of Nabriva Therapeutics AG (Nabriva or the
Company) resolved to implement a stock option plan for all employees being employed by the Company for an indefinite period of time at 28 September 2007 and selected members of the Supervisory Board of the Company
and further participants (the Beneficiaries), a copy of which is attached hereto as Schedule 1 (the Stock Option Plan or SOP); 

WHEREAS, on 17 September 2009 the shareholders of the Company resolved to amend the SOP and thus, the Stock Option Plan was amended through the Addendum
to the SOP dated 12 September 2007 regarding the implementation of preferred vested option rights for selected executives, a copy of which is attached hereto as Schedule 2 (the First Addendum). 

WHEREAS, on 7 May 2010 the shareholders of the Company resolved to further amend the SOP according to the shareholders’ resolution through this
second addendum to the SOP (the Second Addendum). 
  

	1.	INTERPRETATION 

  

	1.1	Definitions 

 Unless explicitly stated otherwise herein, all capitalized terms used in this Second
Addendum shall have the meaning assigned to them in the SOP. 
  

	1.2	Supplemental 

 Except as explicitly provided herein, the SOP and the First Addendum shall remain in full
force and effect, and the First Addendum, this Second Addendum and the SOP shall be read and construed as one document. 
  

	2.	AMENDMENTS TO THE SOP 

 Section II. A.1
(“Vesting”) and A.3 (“Exercising vested options”) of the SOP is replaced so that it reads as follows: 

“1. Vesting 
 The period in
which granted options are vested in accordance with the SOP (“Vesting Period”) shall be four years. The Vesting Period shall commence on the date of participation of the Beneficiaries in this SOP (“Date
of Participation”) as set out in Annex ./3 hereto, but in any event not before 28 September 2007. The total number of granted options eligible to be vested per Beneficiary is set out in Annex ./2 hereto. 

  
 Page 2 

 (i) Year 1 

On the last day of the last calendar month of the first year of the Vesting Period following the Date of Participation, 25 % of the options eligible to
be vested per Beneficiary shall be vested automatically with that Beneficiary. 
 (ii) Year 2 

On the last day of the last calendar month of the second year of the Vesting Period following the Date of Participation, 25 % of the options eligible
to be vested per Beneficiary shall be vested automatically with that Beneficiary. 
 (iii) Year 3 and Year 4 

During the third and fourth year of the Vesting Period following the Date of Participation, the remaining 50 % of the options eligible to be vested per
Beneficiary shall be vested with that Beneficiary on a monthly pro rata basis (i.e. 2.083 % per month). Options eligible to be vested for any given month in years three and four of the Vesting Period will be vested automatically on the last day
of each calendar month. 
 Notwithstanding the above, regarding all Beneficiaries that have worked for the Company prior to their Date of
Participation in the SOP, (i) 25 % of the options eligible to be vested per Beneficiary shall be vested automatically on the last day of the month marking the (first) anniversary of their employment with the Company following their Date of
Participation and (ii) 25 % of the options eligible to be vested per Beneficiary shall be vested automatically on the last day of the month marking the following next anniversary of their employment with the Company. The remaining
50 % of the options shall be vested with that Beneficiary on a monthly pro rata basis (i.e. 2.083 % per month) as set forth in (iii) above. 

Certain Beneficiaries that have worked for the Company for a minimum period of at least one year prior to their Date of Participation in the SOP (the
“Qualified Beneficiaries”) shall be vested 25 % of the options eligible to be vested per Beneficiary under the SOP as set forth in Annex ./2 and ./3 immediately on the Date of Participation of the Qualified
Beneficiaries. 25 % of the options eligible to be vested shall be vested on the last day of the month marking the anniversary of their employment with the Company following their Date of Participation, whereas anniversary of their employment
with the Company always means February 1 if the Qualified Beneficiary started working for the Company before 1 February 2006. The remaining 50 % of the options shall be vested with that Beneficiary on a monthly pro rata basis (i.e.
2.083 % per month) as set forth in (iii) above. 
 The Company believes this will further enhance the Qualified Beneficiaries’
motivation and solidarity with Nabriva. 
 Options shall be vested to Beneficiaries taking maternity leave (“Maternity Leave
Employees”) in accordance with this Clause II.A. 1, provided that (i) options shall not be vested during the time the Maternity Leave Employee is on maternity leave and (ii) options shall only be vested when the
Maternity Leave Employee has worked for Nabriva for a continuous period (such period calculated from the first day the Maternity Leave Employee resumes work after maternity leave) of at least (x) 12 months or (y) 1 month if the Maternity
Leave Employee is participating in the third or fourth year of the Vesting Period pursuant to item (iii) in this Clause. 

  
 Page 3 

 For the avoidance of doubt, options vested prior to the Maternity Leave Employee having taken maternity leave
shall not be forfeited. 
 Notwithstanding the foregoing, the first 25% of the options eligible to be vested with the beneficiary listed in
Schedule 3 after the second year in accordance with (i) above shall be vested automatically with that beneficiary listed in Schedule 3 on 7 May 2010.” 

“3. Exercising vested options 

The exercise of a vested option is only permissible in case of a Liquidation Event or a Qualified Public Offering. The Beneficiaries are entitled to
exercise the vested options from 28 September 2007 until 27 September 2017 (the Exercise Period). Save for the case of a Liquidation Event the Beneficiaries are entitled to exercise vested options exclusively within a
period commencing the day after the Company’s annual general meeting and ending six weeks after that day. 
 In order to exercise a vested
option, the Beneficiary must notify the Company by submitting an exercise notice to the Company in the form of Annex ./4 (Exercise Notice) one week prior to the date he wishes to exercise the option as specified in the Exercise
Notice. 
 In case of a Qualified Public Offering, the transfer of the shares to the Beneficiaries due to the exercise of options under this SOP is
effected only upon completion of the Qualified Public Offering. 
 In case of a Liquidation Event, the Beneficiaries will – following their
exercise of options – only receive a portion of the remainder, if any, of the proceeds from such Liquidation Event after satisfaction of the holders of certain preferred shares pursuant to liquidation preference agreements as in force at the
date of exercise of options, whereas the Beneficiaries will participate in such remainder, if any, pro rata corresponding to their shareholding in the Company (in case Shares would have been transferred to the Beneficiaries); whereas the Company in
case of a distributable remainder in its sole discretion may opt to provide the Beneficiaries with Shares in the Company rather than with cash amounts. A Beneficiary’s obligation to deposit the Exercise Price shall be subject to notification by
the Company that a distributable remainder exists. 
 Notwithstanding the foregoing, the executives listed in Schedule 2 hereto shall be
entitled to exercise their respective vested option at any time prior to 31 December 2009 by giving an Exercise Notice regardless of whether a Liquidation Event or a Qualified Public Offering has occurred. Furthermore, the executive listed in
Schedule 3 hereto shall be entitled to exercise his Preferred Vested Option Right at any time after the resolution of the shareholders dated 7 May 2010 but prior to 31 December 2010] by giving an Exercise Notice regardless of
whether a Liquidation Event or a Qualified Public Offering has occurred (each a Preferred Vested Option Right). 

  
 Page 4 

 In case such Preferred Vested Option Right is exercised, such executive’s receipt of the Shares shall be
subject to the executive’s accession to the Shareholders Agreement, then in force, entered into between the shareholders of the Company, and thus, the executive shall become a Party thereto with all rights and obligations entailed therein. The
Preferred Vested Option Rights are granted to the abovementioned executives only because of their valuable contribution and commitment to the Company and as an additional incentive to further enhance the forthcoming the business thereof.”

  
 Page 5 

 Schedule ./2 
  

	
	 Beneficiaries - Preferred Vested Option Right

 

	Dr. Rodger Novak - Leberstrasse 20, A-1110 Wien - geb. 22.06.1967 - Mitglied des Vorstandes
	Ralf Schmid - Leberstrasse 20, A-1110 Wien - geb. 12.04.1967 - Mitglied des Vorstandes
	Dr. William Prince - Leberstrasse 20, A-1110 Wien - geb. 06.01.1946 - Mitglied des Vorstandes

 Schedule ./3 
  

	
	 Beneficiaries - Preferred Vested Option Right

 

	Dr. William Prince - Leberstrasse 20, A-1110 Wien - geb. 06.01.1946 - Mitglied des Vorstandes

  
 THIRD ADDENDUM 

with regard to the 
 Nabriva
Therapeutics AG’s 
 Stock Option Plan 

dated 12 September 2007 

 PREAMBLE 

WHEREAS, on 12 September 2007, the Management Board and the Supervisory Board of Nabriva Therapeutics AG (Nabriva or the
Company) resolved to implement a stock option plan for all employees being employed by the Company for an indefinite period of time at 28 September 2007 and selected members of the Supervisory Board of the Company and further
participants (the Beneficiaries), a copy of which is attached hereto as Schedule 1 (the Stock Option Plan or SOP); 

WHEREAS, on 17 September 2009, the shareholders of the Company resolved to amend the SOP and thus, the SOP was amended through the Addendum to the SOP
dated 12 September 2007 regarding the implementation of preferred vested option rights for selected executives, a copy of which is attached hereto as Schedule 2 (the First Addendum); 

WHEREAS, on 7 May 2010, the shareholders of the Company resolved to further amend the SOP and thus, the SOP was amended through the Addendum to the SOP
dated 12 September 2007 regarding the implementation of preferred vested option rights for selected executives, a copy of which is attached hereto as Schedule 3 (the Second Addendum); 

WHEREAS, on 30 June 2015, the shareholders of the Company resolved to further amend the SOP according to the shareholder’s resolution through this
third addendum to the SOP (the Third Addendum); 
  

	1.	INTERPRETATION 

  

	1.1	Definitions 

 Unless explicitly stated otherwise herein, all capitalized terms used in this Third
Addendum shall have the meaning assigned to them in the SOP. 
  

	1.2	Supplemental 

 Except as explicitly provided herein, the SOP, the First Addendum and the Second Addendum
shall remain in full force and effect, and the SOP, the First Addendum, the Second Addendum and this Third Addendum shall be read and construed as one document. 
  

	2.	AMENDMENTS TO THE SOP 

  

	2.1	Amendment to Section II. A.3 

 The first three paragraphs of Section II. A.3 (“Exercising vested
options”) of the SOP, as amended by the First Addendum and further amended by the Second Addendum, shall be deleted and replaced in their entirety by the following: 

The Beneficiaries are entitled to exercise the vested options from 28 September 2007 until 27 September 2017 (the Term). Unless otherwise
specifically permitted in the Accession Statement as set forth in Annex ./3 or resolved upon by the Management Board with the approval of the Supervisory Board, the exercise of a vested option is only permissible in case of a Liquidation Event or
following an initial public offering occurring during the Term, regardless of whether or not the Beneficiary is then providing services to the Company. In the case of a Liquidation Event occurring prior to an initial public offering of the Company,
the Beneficiaries are entitled to exercise their vested options, taking into account any 

 
vesting acceleration provided for under II.B.4 hereof, within the six-week period commencing the day after notification of all Beneficiaries of the upcoming Liquidation Event; provided that, if
the acquiring or succeeding corporation (or an affiliate thereof) assumes any options in the Liquidation Event, such assumed options may be exercised, to the extent vested, in accordance with their terms and II. B.4 hereof, at any time during the
remainder of the Term while the Beneficiary is providing services to the acquiring or succeeding corporation (or an affiliate thereof) and within the three-month period following a termination of the Beneficiary’s services to such entity due to
a Good Leaver Event. In the case of an initial public offering, the Beneficiaries are entitled to exercise their vested options at any time, following such offering, during the remainder of the Term. The period during which an option may be
exercised is the Exercise Period. 
 In order to exercise a vested option, the Beneficiary must notify the Company by submitting an exercise notice
to the Company in the form of Annex ./4 (the Exercise Notice) one week (or such shorter period as is permitted by the Company) prior to the date he wishes to exercise the option as specified in the Exercise Notice. 

 

	2.2	Amendment to Section II. B.4 

 The last paragraph of Section II. B.4 shall be deleted in its entirety.

  

	2.3	Amendments to Annex ./1 

  

	(1)	The following new definition shall be added to Annex ./1 I. Definitions: 

 Term has the meaning ascribed
thereto in Clause II.A.3 (“Exercising vested options”). 
 (2) The definition of “Qualified Public Offering” shall be deleted in
its entirety from Annex ./1 I. Definitions. (For the avoidance of doubt, any remaining references to “Qualified Public Offering” in the SOP, or the First Addendum or Second Addendum thereto, shall be read to mean “initial public
offering”.)EX-10.2

 Exhibit 10.2 

Nabriva Therapeutics AG 

Amended and Restated Stock Option Plan 2015 

I. INTRODUCTION 
  

	(A)	On April 2, 2015 the shareholders, the Management Board and the Supervisory Board of Nabriva Therapeutics AG (Nabriva or the Company) resolved to implement a stock option plan under
which the Company’s employees, including members of the Management Board, and members of the Supervisory Board are eligible to receive options to purchase Shares of the Company (any recipient of an award of options, a
Beneficiary). On 30 June 2015 the shareholders of the Company resolved to amend the stock option plan so implemented by approving this Amended and Restated Stock Option Plan 2015 (the amended and restated plan, as it may be
amended from time to time, the SOP 2015). 

  

	(B)	Options granted hereunder entitle each Beneficiary to acquire Shares in Nabriva or otherwise settle the options under the conditions set forth herein. Nabriva believes that this SOP 2015 enhances the commitment of
the Beneficiaries to contribute to Nabriva’s success by allowing them to participate in the increase in the value of the Company and thereby aligns the interests of the Beneficiaries with those of the Company’s shareholders.

  

	(C)	Each Beneficiary will receive an Accession Statement (the form of which is attached hereto at Annex ./2) informing the Beneficiary of the SOP 2015 and any awards made to the Beneficiary under it. The
provisions set forth herein regulate the SOP 2015 in its entirety. If any of the information communicated to the potential participants of the SOP 2015 diverges from this SOP 2015, the provisions of this SOP 2015 shall prevail.

  

	(D)	Options pursuant to this SOP 2015 are neither granted as remuneration nor as bonus in exchange for the performance of Beneficiaries during a specific period. Rather, the participation in the SOP 2015 and the
vesting of options pursuant to this SOP 2015 constitute a voluntary benefit of the Company. Following the nature of voluntary benefits these are solely granted to foster the motivation and solidarity of all Beneficiaries. 

II. STRUCTURE OF THE STOCK OPTION PLAN 

A. Options 
 Subject to adjustment as set
forth in Clause II.D.13 hereof, options may be granted and vested to all Beneficiaries under the SOP 2015 for up to 95,000 Shares (the Overall Number of Options). The number of Shares subject to any option granted to a Beneficiary is
set forth on such Beneficiary’s Accession Statement. If an option granted under the SOP 2015 expires or is terminated, surrendered or canceled without having been fully exercised or is forfeited in whole or in part or otherwise results in
Shares not being issued, the unused Shares shall again be available for the grant of options. Notwithstanding the date and duration of their participation herein and without prejudice to the provisions of this SOP 2015, no person (whether or
not he or she is already a Beneficiary under the SOP 2015) shall be entitled to (further) options under this SOP 2015 once the Overall Number of Options are granted, taking into account any permitted share recycling as set forth herein, unless
the shareholders of Nabriva resolve upon an increase of the Overall Number of Options. 

	1.	Vesting 

  

	1.1	The period in which granted options are vested in accordance with the SOP 2015 shall be four years (Vesting Period) unless otherwise determined by the Company; except with respect to options awarded
to members of the Supervisory Board, any alternative vesting period determined by the Company must be approved by the Supervisory Board or the Management Board. The Vesting Period with respect to a Beneficiary shall commence on the Date of
Participation. 

  

	 	(i)	Year 1 

 On the last day of the last calendar month of the first year of the Vesting
Period following the Date of Participation, 25% of the options eligible to be vested per Beneficiary shall be vested automatically with that Beneficiary. 
  

	 	(ii)	Year 2, Year 3 and Year 4 

 During the second, third and fourth years of the Vesting
Period following the Date of Participation, the remaining 75% of the options eligible to be vested per Beneficiary shall be vested with that Beneficiary on a monthly pro rata basis (i.e. 2.083% per month). Options eligible to be vested for any
given month in years two, three and four of the Vesting Period will be vested automatically on the last day of each calendar month. 
  

	1.2	Options shall be vested to Beneficiaries taking maternity leave (Maternity Leave Employees) in accordance with this Clause II.A.1, provided that options shall not be vested during the time the Maternity
Leave Employee is on maternity leave 

  

	1.3	For the avoidance of doubt, options vested prior to the Maternity Leave Employee having taken maternity leave shall not be forfeited. 

 

	2.	Exercise Price 

  

	2.1	The exercise price per option shall be equal to 100% of the Fair Market Value per Share on the Date of Participation (the Exercise Price). If the Management Board, Supervisory Board, or shareholders, as
the case may be, approve the grant of an option with an Exercise Price to be determined on a future date, the Exercise Price shall be equal to 100% of the Fair Market Value on such future date. 

 

	2.2	Subject to the provisions set forth herein, each vested option entitles a Beneficiary to acquire one Share at the Exercise Price. 

  

	2.3	The Company shall pay for any costs arising in connection with the determination of the Exercise Price. 

  

	3.	Exercising vested options 

  

	3.1	Options granted under the SOP 2015 shall have a term of no more than 10 years from the Date of Participation. 

  

	3.2	 Unless otherwise specifically permitted in the Accession Statement or resolved upon by the Management Board with the approval of the Supervisory
Board, the exercise of a vested option is only permissible in case of a Liquidity Event or following an initial public offering occurring during the term of the option. In the case of a Liquidity Event occurring prior to an initial public offering
of the Company, the Beneficiaries are entitled to exercise their vested options, taking into account any vesting acceleration provided for under Clause II.B.8 

	 	
hereof, within the six-week period commencing the day after notification of all Beneficiaries of the upcoming Liquidity Event; provided that, if the acquiring or succeeding corporation (or an
affiliate thereof) assumes any options in the Liquidity Event, such assumed options may be exercised, to the extent vested in accordance with their terms and Clause II.B.8 hereof, at any time during the remaining term of the option while the
Beneficiary is providing services to the acquiring or succeeding corporation (or an affiliate thereof) and within the three-month period following a termination of the Beneficiary’s services to such entity due to a Good Leaver Event. In the
case of an initial public offering, the Beneficiaries are entitled to exercise their vested options at any time, following such offering, during the remaining term of the option while the Beneficiary is providing services to the Company and within
the three month period following a termination of the Beneficiary’s services due to a Good Leaver Event. The period during which an option may be exercised is the Exercise Period. 

 

	3.3	In order to exercise a vested option, the Beneficiary must notify the Company by submitting an exercise notice to the Company in the form of Annex ./3 (the Exercise Notice) one week (or such shorter
period as is permitted by the Company) prior to the date he wishes to exercise the option as specified in the Exercise Notice. 

  

	3.4	In case of a Liquidity Event, the Beneficiaries will – following their exercise of options – only receive a portion of the remainder, if any, of the proceeds from such Liquidity Event after satisfaction of the
holders of certain preferred shares pursuant to liquidation preference agreements as in force at the date of exercise of options, whereas the Beneficiaries will participate in such remainder, if any, pro rata corresponding to their
shareholding in the Company (in case Shares would have been transferred to the Beneficiaries); whereas the Company in case of a distributable remainder in its sole discretion may opt to provide the Beneficiaries with Shares in the Company rather
than with cash amounts. A Beneficiary’s obligation to deposit the Exercise Price shall be subject to notification by the Company that a distributable remainder exists. 

 

	4.	Rights and restrictions attached to vested options 

  

	4.1	The Beneficiaries shall not be entitled to transfer vested options, except to individuals by way of inheritance or bequest. For the avoidance of doubt, Beneficiaries shall also not be entitled to transfer vested options
by virtue of bilateral legal transactions causa mortis with or without consideration. 

  

	4.2	The Beneficiaries shall not be entitled to grant rights to, encumber or dispose of vested options in any other manner (in particular pledge, transfer by way of security or derivative transactions having the same
commercial effect). 

  

	4.3	Options do not entitle the Beneficiary to exercise any shareholder rights. The Beneficiary may only exercise shareholder rights if and to the extent he holds Shares. 

 

	4.4	In the event of an Insolvency of a Beneficiary, the options not yet exercised by such Beneficiary shall automatically be forfeited. 

  

	4.5	Any options not exercised by the end of the Exercise Period shall automatically and finally lapse and be forfeited. 

B. Termination of Employment or Board Position 

In case a Beneficiary’s services to the Company are terminated, the following shall apply: 

	5.	Good Leaver Events 

  

	5.1	If a Beneficiary’s service or employment relationship ends during the term of the SOP 2015 due to (and each of the following a Good Leaver Event) 

 

	 	(i)	retirement due to age or permanent disability (Ausscheiden aufgrund Alters oder dauernder Arbeitsunfähigkeit); 

  

	 	(ii)	death; 

  

	 	(iii)	ordinary termination by maintaining the contractual or statutory periods and deadlines (ordentliche Kündigung) by the Company or the Beneficiary; 

 

	 	(iv)	justified premature resignation with immediate effect (berechtigter vorzeitiger Austritt); 

  

	 	(v)	unjustified dismissal (ungerechtfertigte Entlassung); 

  

	 	(vi)	mutual termination (einvernehmliche Auflösung); 

  

	 	(vii)	expiry of a Management Board or Supervisory Board mandate (Nichtverlängerung eines Mandats); 

  

	 	(viii)	premature revocation of a Management Board or Supervisory Board mandate without good cause (Abberufung ohne wichtigen Grund); or 

 

	 	(ix)	resignation of a member of the Management Board or Supervisor Board with good cause (Rücktritt aus wichtigem Grund); 

all rights and entitlements under the SOP 2015 to the options which have not been vested upon the occurrence of a Good Leaver Event shall
be automatically forfeited. For the avoidance of doubt, except as otherwise determined by the Supervisory Board, with respect to members of the Management Board, or the shareholders, with respect to members of the Supervisory Board, none of the
events set forth in (vii), (viii) or (ix) shall constitute a termination of services to the extent the board member continues to provide services to the Company as an employee or otherwise. Options eligible to be vested to a Beneficiary in
a fiscal year which are not actually vested in respect of such Beneficiary in that fiscal year shall not be available to that Beneficiary at any other time. 
  

	5.2	Beneficiaries with options vested but not exercised at the time of a Good Leaver Event shall retain such options and be entitled to exercise such options according to the provisions set forth herein. 

 

	6.	Bad Leaver Events 

  

	6.1	If a Beneficiary’s service or employment relationship with the Company ends during the term of the SOP 2015 due to an event other than a Good Leaver Event (a Bad Leaver Event), all options of the
Beneficiary vested but not exercised at the time a Bad Leaver Event occurs shall be forfeited. The revocation of a member of the Management Board pursuant to a vote of non-confidence by the General Assembly (Vertrauensentzug) shall not
constitute a Bad Leaver Event as long as no reason for justified dismissal is set by the Beneficiary. 

  

	6.2	The Supervisory Board may within its discretion decide whether to grant to a Beneficiary advantages as from a Good Leaver event even though the end of a Beneficiary’s service or employment relationship constitutes
a Bad Leaver Event as described in this Clause II.B.6. In case the Beneficiary concerned functions as a member of the Supervisory Board, the shareholders shall decide on the advantages granted to the Beneficiary as set forth above.

	7.	Exercised options 

 The termination of a service or an employment relationship with the
Company shall have no effect on options that were exercised prior to the date of a declaration of termination of the Beneficiary’s services. 
  

	8.	Accelerated Vesting 

 In case a Liquidity Event occurs, all options outstanding under the
SOP 2015 at such time, shall be assumed, or substantially equivalent options shall be substituted, by the acquiring or succeeding corporation (or an affiliate thereof) and any such options that are not yet vested shall continue to become vested in
accordance with the original vesting schedule set forth on the Beneficiary’s original Accession Statement. However, each such option shall be immediately exercisable in full if, on or prior to the first anniversary of the date of the
consummation of the Liquidity Event, the Beneficiary’s services with the Company or the acquiring or succeeding corporation (or an affiliate thereof) is terminated due to a Good Leaver Event. If the acquiring or succeeding corporation (or an
affiliate thereof) refuses to assume or substitute substantial equivalent options in accordance with the first sentence of this Clause II.B.8, then all remaining options not yet vested with a Beneficiary at the time of such Liquidity Event shall
vest with the Beneficiaries with immediate effect. 
 C. Duration, Expiry, Amendments to and Termination of 
the Stock Option Plan

  

	9.	Duration and Expiry 

  

	9.1	The SOP 2015 shall become effective on upon the registration of the conditional capital increase of the Company resolved upon in the shareholders’ meeting on 30 June 2015 with the commercial register (the
Effective Date). 

  

	9.2	No options shall be granted under the SOP 2015 after the expiration of 10 years from the Effective Date, but options previously granted may extend beyond that date. 

 

	10.	Amendments 

  

	10.1	The Management Board, Supervisory Board or shareholders, as the case may be, may amend, modify or terminate any outstanding option. The Beneficiary’s consent to such action shall be required unless (i) the
Management Board, Supervisory Board or shareholders, as the case may be, determine that the action, taking into account any related action, does not materially and adversely affect the Beneficiary’s rights under the SOP 2015 or (ii) the
change is permitted under Clause II.D.13. 

  

	10.2	The Management Board may amend, suspend or terminate the SOP 2015 or any portion thereof at any time; provided that if at any time the approval of the Company’s shareholders is required, including by
application of Austrian law, the Management Board may not effect such modification or amendment without such approval. Unless otherwise specified in the amendment, any amendment to the SOP 2015 adopted in accordance with this Clause II.C.10.2 shall
apply to, and be binding on the Beneficiaries of, all options outstanding under the SOP 2015 at the time the amendment is adopted, provided the Management Board or shareholders, as the case may be, determine that such amendment, taking into account
any related action, does not materially and adversely affect the rights of Beneficiaries under the SOP 2015. 

	11.	Termination 

 The Company may terminate any option granted to a Beneficiary under the SOP
2015 for good cause if that Beneficiary breaches significant statutory or contractual obligations in connection with its service or employment relationship with the Company. Such good cause shall be a reason pursuant to sec 75 Austrian Stock Company
Act (Aktiengesetz) for members of the Management Board and the Supervisory Board of the Company and pursuant to sec 27 Austrian Employees Act (Angestelltengesetz) for employees of the Company whereby the revocation of a member of the
Management Board pursuant to a vote of non-confidence (Vertrauensentzug) by the shareholders shall not constitute such good cause in the meaning of this paragraph as long as no reason for justified dismissal is set by the Beneficiary. To the
extent the members of the Management Board are affected, the Supervisory Board shall exercise such termination right. To the extent members of the Supervisory Board are affected, the Company’s shareholders shall be competent to resolve upon
such termination by simple majority. 
 D. Risks 
  

	12.	Risks 

  

	12.1	Neither the Company nor any shareholder of the Company (or any of their officers, employees or consultants) 

  

	 	(i)	assumes any responsibility or liability for the development of the value of the market price of the Shares; 

  

	 	(ii)	warrant, assure or guarantee any increase in value of the Shares, in particular it is neither warranted, assured or guaranteed that a Beneficiary will be able to sell his participation in the Company with a profit in
the future nor that no loss will be incurred; 

  

	 	(iii)	warrant, assure or guarantee a profit of a Beneficiary from this SOP 2015; 

  

	 	(iv)	makes any representations or warranty and shall have no liability to the Beneficiary or any other person if any provisions of or payments, compensation or other benefits under the SOP 2015 are determined to constitute
nonqualified deferred compensation subject to Section 409A of the Internal Revenue Code but do not to satisfy the conditions of that section. 

  

	12.2	Each Beneficiary declares with his participation in the SOP 2015 that the participation is voluntary. Each Beneficiary is aware of the fact that he alone bears the risk of a decrease in or total loss of value of
his investments. Each Beneficiary accepts the offer to participate in the SOP 2015 at his own risk and assumes any liability relating thereto. 

  

	12.3	Each Beneficiary is responsible for obtaining legal and tax advice before participating in the SOP 2015 and for evaluating the tax effects connected with the SOP 2015. Each Beneficiary accepts and declares
that he has not been advised by or on behalf of the Company with respect to his participation in the SOP 2015 (in particular regarding legal and tax issues of the participation). 

 

	12.4	The Company declares to undertake the best efforts for a risk minimal and tax efficient settlement of this SOP 2015. 

 D. Miscellaneous 
  

	13.	Stock Adjustments 

  

	13.1	If, during the term of the SOP 2015, changes to the capital of the Company or restructuring measures have an effect on the capital of the Company, such as a stock split or reverse split of stocks, (together
Stock Adjustments) which result in a change in the value of the options, the Company is entitled to adjust the price or the amount of the options respectively, to the extent necessary to compensate changes in value (but not a dilution
of shareholding) resulting from any Stock Adjustments. For the avoidance of doubt, this Clause II.D.13 shall not apply to measures, such as future financing rounds, in which new shareholders of the Company are introduced. 

 

	13.2	The Supervisory Board decides on an adjustment based on a proposal by the Management Board. After execution of the Stock Adjustments the total value of the granted options shall equal the total value of the options
before execution of such Stock Adjustments. The Company will inform the Beneficiaries about the Stock Adjustment and the effective date of the Stock Adjustment. 

  

	14.	Agreement in connection with an Initial Public Offering 

  

	14.1	Each Beneficiary agrees, in connection with the initial underwritten public offering of Shares pursuant to a registration statement under the Securities Act, (i) not to (a) offer, pledge, announce the
intention to sell, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose of, directly or indirectly, any Shares or
any other securities of the Company or (b) enter into any swap or other agreement that transfers, in whole or in part, any of the economic consequences of ownership of Shares or other securities of the Company, whether any transaction described
in clause (a) or (b) is to be settled by delivery of securities, in cash or otherwise, during the period beginning on the date of the filing of such registration statement with the United States Securities and Exchange Commission and
ending 180 days after the date of the final prospectus relating to the offering (plus up to an additional 34 days to the extent requested by the managing underwriters for such offering in order to address Rule 2711(f) of the National Association of
Securities Dealers, Inc. or any similar successor provision), and (ii) to execute any agreement reflecting clause (i) above as may be requested by the Company or the managing underwriters at the time of such offering. The Company may
impose stop-transfer instructions with respect to the Shares or other securities subject to the foregoing restriction until the end of the “lock-up” period. 

 

	15.	No business practice (“Betriebliche Übung”) 

  

	15.1	The granting of options and the implementation of the SOP 2015 is the free and discretionary choice of the Company, constitutes a voluntary benefit and shall not give rise to any legal claim by a Beneficiary for
the future, not even in the case of repeated granting. 

  

	15.2	Beneficiaries of the SOP 2015 do not have a right for the introduction of another option plan or any vesting of options in addition to those under the SOP 2015, even if the Company implements any other option
plan or vests further options under any other option plan. 

  

	15.3	Vested options under this SOP 2015 do not affect the calculation of severance, premiums, royalties, pension plans or any other remuneration of the Beneficiary. 

 

	16.	Taxes, duties and social contributions 

  

	16.1	 All taxes, social contributions, further duties and costs accrued by the Beneficiary in connection with its participation in the SOP 2015 or due
to the distribution of profits shall be borne by each Beneficiary. Each 

	 	
Beneficiary is obliged to pay taxes relating to the respective options granted/exercised under the SOP 2015 to the competent tax authorities, also in the course of tax audits or any other
procedures. Each Beneficiary shall fully indemnify the Company in respect of all such liabilities and obligations against tax authorities. 

  

	16.2	The employer of the Beneficiary is entitled, if required by statutory law, to withhold wage tax or any other taxes or duties or social contributions to be paid by the Beneficiary. This applies even after termination of
the employment of a Beneficiary with the Company, if the vested options granted are non-lapsable but not yet exercisable. The Company is entitled to demand the full cooperation of the Beneficiary even after his leave with respect to the withholding
of taxes, social contributions, other duties and costs in connection with this SOP 2015. The Beneficiary undertakes to co-operate. 

  

	16.3	Withholdings mentioned above do not release the Beneficiary from his responsibility and obligation to pay all taxes, social contributions, further duties and costs being due and accruing in connection with his
participation in the SOP 2015 or in connection with the distribution of profits. 

  

	17.	Notices 

  

	17.1	Notifications to the Company with respect to the terms of the SOP 2015 shall only be made to: 

Nabriva Therapeutics AG 

Corporate Human Resources 
 fax:
+43 1 74093 1202 
 email: ralf.schmid@nabriva.com 
  

	17.2	Notifications by the Company to the Beneficiary relating to the SOP 2015 shall be made in writing (including email or fax) to each Beneficiary to the respective Beneficiary’s address last disclosed to the
Company. 

  

	18.	Saving provisions 

 If any provision of this SOP 2015 in full or in part is or
becomes invalid, this shall not affect the validity of all other provisions or the valid part of an invalid provision. To the extent legally possible, an agreement shall be made replacing the invalid provision by a provision which best meets the
intent of the terms of the SOP 2015. The same applies to loopholes of the terms of the SOP 2015, which may arise in the course of implementation of the terms of the SOP 2015. 

 

	19.	Governing law and jurisdiction 

 The terms of the SOP 2015, its interpretation and
all rights and obligations arising there from shall be governed by Austrian law, except for international private law and the UN Convention on Contracts for the International Sales of Goods. The courts of Vienna, Austria, shall, to the extent
legally possible, have exclusive jurisdiction regarding all claims in connection with and the terms of the SOP 2015. 
 Annex: 

	./1	Definitions 

	./2	Accession Statement 

	./3	Exercise Notice 

 Annex ./1 

I. Definitions 
  

			
	Bad Leaver Event		has the meaning ascribed thereto in Clause II.C.2
		
	Insolvency		means the initiation of insolvency proceedings in regard to the assets of a Beneficiary, the dismissal of an application for insolvency due to a lack of assets or the initiation of private insolvency proceedings pursuant to secs.
181 et seq. of the Austrian Insolvency Code (“IO”) or any equivalent rule in any other relevant jurisdiction
		
	Beneficiary		is any employee (for the avoidance of doubt including any member of the Management Board), member of the Supervisory Board of the Company or any other individual eligible to receive options hereunder, who receives an award of
options
		
	Company		Nabriva Therapeutics AG and its legal successors
		
	Date of Participation		means the date on which an option is awarded and the recipient becomes a Beneficiary in this SOP 2015. A Beneficiary’s Date of Participation is set forth on the Beneficiary’s Accession Statement
		
	Effective Date		has the meaning ascribed thereto in Clause II.C.9
		
	Exercise Notice		has the meaning ascribed thereto in Clause II.A.3
		
	Exercise Period		has the meaning ascribed thereto in Clause II.A.3
		
	Exercise Price		has the meaning ascribed thereto in Clause II.A.2
		
	Fair Market Value		 shall, for each Share for purposes of the SOP 2015, be determined as follows:

 
 (i) if the Shares are not publicly traded, the Management Board, subject to the approval
of the Supervisory Board, will determine the Fair Market Value for purposes of the SOP 2015 on the basis of an enterprise value of the Company of US$148,045,201 as determined by the independent third-party expert evaluator Duff & Phelps B.V. as
of March 31, 2015, and taking into account any measure of value it determines to be appropriate to reflect changes in the value of the Company since March 31, 2015 in a manner consistent with the valuation principles under Section 409A of
the Internal Revenue Code;
  
 (ii) if the Shares trade on a national securities
exchange, the closing sale price (for the primary trading session) on the Date of Participation; or
  

			
		
			 (iii) if the Shares do not trade on any such exchange, the average of the closing bid and asked prices as reported by an authorized OTCBB
market data vendor as listed on the OTCBB website otcbb.com) on the Date of Participation.
  

For any date that is not a trading day, the Fair Market Value of a Share for such date will be determined by using the closing sale price or average of the bid
and asked prices, as appropriate, for the immediately preceding trading day and with the timing in the formulas above adjusted accordingly. The Management Board can substitute a particular time of day or other measure of “closing sale
price” or “bid and asked prices” if appropriate because of exchange or market procedures or can, in its sole discretion, use weighted averages either on a daily basis or such longer period as complies with Section 409A of the Internal
Revenue Code.
  
 The Management Board and Supervisory Board have, within the framework
determined by the shareholders in this SOP 2015, sole discretion to determine the Fair Market Value for purposes of the SOP 2015, and all options are conditioned on the Beneficiary’s agreement that the Management Board’s and Supervisory
Board’s determination is conclusive and binding even though others might make a different determination.

		
	Good Leaver Event		has the meaning ascribed thereto in Clause II.B.5
		
	Internal Revenue Code		means the United States Internal Revenue Code of 1986, as amended or any successor thereto
		
	Liquidity Event		 means:
  

(i) an exclusive license of or the sale, the lease or other disposal of all or substantially all of the assets of the Company;

 
 (ii) a sale or other disposal (for the avoidance of doubt, the term disposal shall not
include a pledge) in any transaction or series of transactions to which the Company is a party of 50% or more of the voting power of the Company, other than any transaction or series of transactions principally for bona fide equity financing
purposes in which cash is received by the Company or indebtedness of the Company is cancelled or converted, or a combination thereof;
  

(iii) a merger or consolidation of the Company with or into any third party, other than any merger or consolidation in which the shares of the Company
immediately preceding such merger or consolidation continue to represent a majority of the voting power of the surviving entity immediately after the closing of such merger or consolidation; and

 

			
		
			(iv) a liquidation, winding up or any other form of dissolution of the Company.
		
	Management Board		means the management board (Vorstand) of the Company
		
	Maternity Leave Employees		has the meaning ascribed thereto in Clause II. A
		
	Overall Number of Options		has the meaning ascribed thereto in Clause II. A
		
	Securities Act		means the United States Securities Act of 1933
		
	Shares and each a Share		means the common shares of the Company issued from time to time
		
	SOP 2015		has the meaning ascribed thereto in Clause I
		
	Supervisory Board		means the supervisory board (Aufsichtsrat) of the Company
		
	Vesting Period		has the meaning ascribed thereto in Clause II.A.1

 Annex ./2 

Form of Accession Statement 
 To: 

Ms / Mr [•], 
 [address] 

REF: SOP 2015 / Accession Statement 
 Dear Ms / Mr
[•], 
 You will participate in this SOP 2015 with effect as of [•] (Participation Date). 

As Participant in the SOP 2015 you will be granted options to acquire shares in the Company pursuant to this SOP 2015 in the amounts as set forth in
the Vesting Table attached. 
  
  

Nabriva Therapeutics AG: 
 DATE: 

PARTICIPANT: 
 DATE: 

Annex: 
  

	./	Vesting Table 

 Annex ./3 

Form of Exercise Notice 
 To: 

Nabriva Therapeutics AG  
 Corporate Human Resources 

Leberstraße 20 
 1010 Vienna, Austria 

REF: SOP 2015 / Exercise Notice 
 Dear Sirs, 

I am a participant in the SOP 2015. Capitalized terms not otherwise defined herein shall have the meaning assigned to such term in the SOP 2015. This
is an Exercise Notice. 
 I hereby irrevocably declare to exercise [•] vested options granted to me [on •] 

 

	 	‰	When exercising the above number of options, I wish to acquire [•] Shares as determined in the vesting table attached to my Accession Statement at the Exercise Price per Share. Such Shares shall be delivered to my
securities account no. [•] with [•] against payment in cash by me of the Exercise Price for each Share. I acknowledge that I must satisfy any applicable tax withholding (including social security contributions) resulting from the exercise
of my options by making a cash payment to the Company (or otherwise in a manner as the Company may permit) before any Shares will be delivered to me. 

  

	 	‰	Whereas in the case of a Liquidity Event, (i) I acknowledge that in case of a distributable remainder the Company – in consideration of the Exercise Price – in its sole discretion may opt to provide me
with Shares in the Company rather than with the cash amounts attributable to me according to the SOP 2015, (ii) I shall deposit the Exercise Price only upon notification by the Company that a distributable remainder exists, (iii) upon
such notification, I shall deposit the Exercise Price within seven (7) business days. 

 I acknowledge that options have not been granted
as remuneration or as a bonus for job performance but rather as a voluntary benefit to encourage motivation and solidarity with the Company and that I have no entitlement to any future comparable benefits. 

Name 
 Date

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00247-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00247-of-00352.parquet"}]]